These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 18454852)
1. Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism. Androutsopoulos V; Arroo RR; Hall JF; Surichan S; Potter GA Breast Cancer Res; 2008; 10(3):R39. PubMed ID: 18454852 [TBL] [Abstract][Full Text] [Related]
2. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Androutsopoulos VP; Ruparelia K; Arroo RR; Tsatsakis AM; Spandidos DA Toxicology; 2009 Oct; 264(3):162-70. PubMed ID: 19666078 [TBL] [Abstract][Full Text] [Related]
3. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids. Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471 [TBL] [Abstract][Full Text] [Related]
4. Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1-mediated metabolism to the product 4' hydroxy tangeretin. Surichan S; Arroo RR; Tsatsakis AM; Androutsopoulos VP Toxicol In Vitro; 2018 Aug; 50():274-284. PubMed ID: 29626627 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells. Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115 [TBL] [Abstract][Full Text] [Related]
6. Nobiletin bioactivation in MDA-MB-468 breast cancer cells by cytochrome P450 CYP1 enzymes. Surichan S; Arroo RR; Ruparelia K; Tsatsakis AM; Androutsopoulos VP Food Chem Toxicol; 2018 Mar; 113():228-235. PubMed ID: 29408579 [TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. Androutsopoulos VP; Mahale S; Arroo RR; Potter G Oncol Rep; 2009 Jun; 21(6):1525-8. PubMed ID: 19424633 [TBL] [Abstract][Full Text] [Related]
8. The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells. Androutsopoulos VP; Li N; Arroo RR J Nat Prod; 2009 Aug; 72(8):1390-4. PubMed ID: 19601638 [TBL] [Abstract][Full Text] [Related]
9. Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via activation of cell signaling proteins and CYP1-mediated metabolism. Androutsopoulos VP; Tsatsakis AM Toxicol Lett; 2014 Oct; 230(2):304-13. PubMed ID: 23994263 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin. Chang TK; Chen J; Yang G; Yeung EY J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. Razak NA; Abu N; Ho WY; Zamberi NR; Tan SW; Alitheen NB; Long K; Yeap SK Sci Rep; 2019 Feb; 9(1):1514. PubMed ID: 30728391 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279 [TBL] [Abstract][Full Text] [Related]
13. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858 [TBL] [Abstract][Full Text] [Related]
14. Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450. Androutsopoulos V; Wilsher N; Arroo RR; Potter GA Cancer Lett; 2009 Feb; 274(1):54-60. PubMed ID: 18976853 [TBL] [Abstract][Full Text] [Related]
15. Modulation of CYP1A1, CYP1A2 and CYP1B1 expression by cabbage juices and indoles in human breast cell lines. Szaefer H; Licznerska B; Krajka-Kuźniak V; Bartoszek A; Baer-Dubowska W Nutr Cancer; 2012 Aug; 64(6):879-88. PubMed ID: 22716309 [TBL] [Abstract][Full Text] [Related]
16. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells. Brantley E; Trapani V; Alley MC; Hose CD; Bradshaw TD; Stevens MF; Sausville EA; Stinson SF Drug Metab Dispos; 2004 Dec; 32(12):1392-401. PubMed ID: 15355884 [TBL] [Abstract][Full Text] [Related]
17. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646 [TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha. Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175 [TBL] [Abstract][Full Text] [Related]
19. Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. van Duursen MB; Sanderson JT; van der Bruggen M; van der Linden J; van den Berg M Toxicol Appl Pharmacol; 2003 Aug; 190(3):241-50. PubMed ID: 12902195 [TBL] [Abstract][Full Text] [Related]
20. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism. Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]